Navigation Links
ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
Date:3/27/2008

BUDAPEST, Hungary, PRINCETON, New Jersey and LONDON, March 27 /PRNewswire/ -- ThalesNano Inc. today announced the launch of the latest in its Cube(TM) flow reactor series, the X-Cube Flash(TM). This novel product is validated with several important chemistry applications. The X-Cube Flash(TM) will be officially unveiled in the US, at the 235th National Meeting of the of the American Chemical Society, held April 6-10 in New Orleans, LA, and in Europe at the Advances in Synthetic Chemistry conference in Frankfurt held on April 8 and 9.

The X-Cube Flash(TM) is designed to carry out homogenous reactions in continuous flow mode at high pressure and temperature, operating safely up to 200 bar and 350 degrees C. This enables chemists to significantly expand the parameter space they can utilize within a regular laboratory setting. The system is also applicable for doing chemistry under supercritical conditions.

Dr. Laszlo Urge, CEO of ThalesNano commented: "We call our latest X-Cube(TM) reactor the "Flash", because most reactions proceed in seconds or minutes instead of hours. The X-Cube Flash(TM) fulfills the need of our customers for safe high pressure and temperature homogenous reactions. In addition it can be used to scale up microwave assisted reactions quickly with little method development. Our experience shows that the system can be utilized to reduce hazardous waste production in many chemical processes. In certain chemical transformations, it also eliminates the need for using expensive and toxic heavy metal catalysts fulfilling the requirements of Green Chemistry. The pharmaceutical industry is increasingly adopting continuous processes and this system can provide a ready state of the art solution for testing and optimizing chemistries for continuous process applications on a larger scale later. The increase in productivity and chemical efficiency can result in significant cost and time savings for those R&D organizations who adopt this technology."

"This product will be a complementary addition to our existing X-Cube(TM) technology. With its launch we have further diversified our continuous process technology portfolio giving ThalesNano the widest product range available in bench top flow chemistry and continuous process technology. The company is executing a complex strategy designed to provide integrated continuous flow solutions from discovery to full scale production which could help solve some of the key bottlenecks in the pharmaceutical, biotechnology and chemical industries" stated Dr. Ferenc Darvas, President and Chairman at ThalesNano.

For more information please refer to ThalesNano's website at http://www.thalesnano.com

About ThalesNano:

ThalesNano is a world-leading provider of continuous process technologies and flow chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors.

The company has the widest portfolio of bench-top continuous process instruments. Its H-Cube(R) continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Midi(TM) are used in hundreds of laboratories in four continents and may become the new industry standard for hydrogenation.

Flow chemistry, an emerging technology, allows the highly effective and rapid synthesis of organic compounds, in particular under hitherto unrealisable hazardous reaction conditions. Additional benefits are seen in the area of Green Chemistry and lab automation. This technology also promotes the rapid scale-up from mg to kg quantities which in the long run could result in lower CAPEX and OPEX.

Contact: Laszlo Urge, Ph.D., CEO, e-mail: ceodirect@thalesnano.com, Telephone: +36-1-880-8500 .


'/>"/>
SOURCE ThalesNano Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
2. Laureate Announces Second Manufacturing Agreement with Cytheris
3. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
4. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
5. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
6. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
7. EnergyNow! Announces New Grant Funding to Combat Childhood Obesity
8. Governor Rendell Announces Own Your Future Campaign; Urges Consumers to Better Plan Their Long-Term Care Needs
9. BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
10. Global Med Technologies(R), Inc. Announces the Sale of Approximately 3.3 Million Shares of Global Med Common Stock Held by SingXpress Ltd., an Asian Company, to Five American Institutions
11. AT&T Announces Grant to Center on Aging-University of Miami Miller School of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... Houma, LA, celebrates the beginning of a new charity campaign. As part of ... Appointed Special Advocates (CASA). In the belief that children deserve a voice, and ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... If you ... much to handle, you are not alone. According to the Center for Disease Control ... disease, stroke, type 2 diabetes and certain types of cancer, some of the leading ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... program serving the greater Venice, FL area, has initiated a fundraiser for a ... car accident just four days after Christmas. To support this beautiful child who ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and post-traumatic ... of women and men with eating disorders report a history of trauma, research ... development of an eating disorder. , At the 2016 iaedp Symposium, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Association of ... AHCC and the Home Health and Hospice ICD-10 Transition Workgroup are working closely ... coding guidance and clarifications, to address concerns over the use of 'A' as ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  HemaFlo Therapeutics, Inc. announced today that ... US Patent Number 9,119,880 covering the use of NephroFlow to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ... --> Dale Peterson , PhD, HemaFlo,s ...
(Date:2/8/2016)... Feb. 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... editing, announced that the U.S. Food and Drug ... Drug (IND) application for SB-318, a single treatment ... Mucopolysaccharidosis Type I (MPS I). The SB-318 IND ... initiate a Phase 1/2 clinical study (SB-318-1502) designed ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: